Related Experiment Video
Updated: Mar 15, 2026

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
Inhibition of osteoblast differentiation by aluminum trichloride exposure is associated with inhibition of BMP-2/Smad
Xu Yang1, Hui Huo2, Chunyu Xiu1
1College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, China.
Abstract:
Bone morphogenetic protein-2 (BMP-2)/Smad signaling pathway plays an important role in regulating osteoblast (OB) differentiation. OB differentiation is a key process of bone formation. Aluminum (Al) exposure inhibits bone formation and causes Al-induced bone disease. However, the mechanism is not fully understood. To investigate whether BMP-2/Smad signaling pathway is associated with OB differentiation in aluminum trichloride (AlCl3)-treated OBs, the primary rat OBs were cultured and exposed to 0 (control group, CG), 1/40 IC50 (low-dose group, LG), 1/20 IC50 (mid-dose group, MG), and 1/10 IC50 (high-dose group, HG) of AlCl3 for 24 h, respectively. We found that the expressions of OB differentiation markers (Runx-2, Osterix and ALP) and BMP-2/Smad signaling pathway components (BMP-2, BMPR-IA, p-BMPR-IA, BMPR-II, p-Smad1/5/8 and p-Smad1/5/8/4) were all decreased in AlCl3-treated OBs compared with the CG. These results indicated that inhibition of OB differentiation by AlCl3 was associated with inhibition of BMP-2/Smad pathway component expression. Our findings provide a novel insight into the mechanism of AlCl3-induced bone disease.
Insights
Aluminum trichloride exposure inhibits osteoblast differentiation by downregulating the Bone morphogenetic protein-2 (BMP-2)/Smad signaling pathway, offering insight into aluminum-induced bone disease mechanisms.
Area of Science:
- Biochemistry
- Cell Biology
- Toxicology
Background:
- Osteoblast (OB) differentiation is crucial for bone formation.
- Aluminum (Al) exposure impairs bone formation, leading to Al-induced bone disease.
- The precise mechanism of Al-induced bone disease remains unclear.
Purpose of the Study:
- To investigate the association between the Bone morphogenetic protein-2 (BMP-2)/Smad signaling pathway and osteoblast differentiation in aluminum trichloride (AlCl3)-treated osteoblasts.
- To elucidate the role of BMP-2/Smad signaling in AlCl3-induced inhibition of bone formation.
Main Methods:
- Primary rat osteoblasts were cultured and exposed to varying concentrations of AlCl3 (0, 1/40, 1/20, 1/10 IC50) for 24 hours.
- Expression levels of osteoblast differentiation markers (Runx-2, Osterix, ALP) were assessed.
- Expression of BMP-2/Smad signaling pathway components (BMP-2, BMPR-IA, p-BMPR-IA, BMPR-II, p-Smad1/5/8, p-Smad1/5/8/4) were measured.
Main Results:
- AlCl3 treatment significantly decreased the expression of osteoblast differentiation markers (Runx-2, Osterix, ALP).
- Expressions of BMP-2/Smad signaling pathway components, including BMP-2, BMPR-IA, p-BMPR-IA, BMPR-II, p-Smad1/5/8, and p-Smad1/5/8/4, were reduced in AlCl3-treated osteoblasts compared to controls.
- A dose-dependent inhibition was observed with increasing AlCl3 concentrations.
Conclusions:
- AlCl3 exposure inhibits osteoblast differentiation.
- The inhibition of osteoblast differentiation by AlCl3 is associated with the downregulation of the BMP-2/Smad signaling pathway.
- These findings provide a novel mechanistic insight into AlCl3-induced bone disease.
Related Concept Videos
TGF - β Signaling Pathway
Osteoclasts in Bone Remodeling
Bone Remodeling

